TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05331482

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training protocol with the cervical device for treatment (CDAT).
Description: Endurance training program of deep cervical flexors and deep cervical extensors with the cervical device for treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional training protocol
Description: Endurance training program of deep cervical flexors and deep cervical extensors with conventional training protocol.
Study: NCT05623865

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: kinesiotaping
Description: Kinesio tape will be attached with lymphedema technique.~The bands will be removed prior to each assessment so that they do not affect the evaluator's blinding. After evaluation, the new tape will be fitted by the invesitgatör

Intervention type: OTHER
Group type: OTHER
Intervention: exercise
Description: Wrist, finger, elbow range of motion and stretching exercises will be taught to the patients and given as home exercises.~In addition, patients will be given a leaflet containing illustrated and explanatory exercise visuals.
Study: NCT04775134

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung biopsy
Description: Biopsy of residuary material from a medically indicated pulmonary resection

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung biopsy
Description: Biopsy of residuary material from a medically indicated pulmonary resection
Study: NCT04837742

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ESPB group
Description: ESPB injection at T10 region with Chirocaine 100mg(20 cc)+ Omnipaque 10cc

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: ESPB injection at T10 region with Normal saline 20cc + Omnipaque 10cc
Study: NCT05213351

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graded Motor Imagery
Description: Graded Motor Imagery program will be performed two times a week for six consecutive weeks and will include the following three steps: laterality training, imagined movements, and mirror therapy.~1. Right-left discrimination training (lateralization training)~2. Imagination of hand movements (motor imagery):~3. Mirror therapy Treatments including traditional physiotherapy approaches; joint mobilizations, stretching, scapula focused exercises etc.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Treatments including traditional physiotherapy approaches; joint mobilizations, stretching, scapula focused exercises etc.
Study: NCT05706402

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Description: Patients will be randomized to receive oral N-acetylcysteine at 600 mg twice daily for 1 week. The randomization will be done via computer software with half of the patients randomized to receive NAC. Patients will also be given standard treatment for your COPD exacerbation and can continue the use of usual inhalers for COPD.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will be randomized to receive placebo for 1 week. The randomization will be done via computer software with half receive placebo. Patients will also be given standard treatment for your COPD exacerbation and can continue the use of usual inhalers for COPD.
Study: NCT05233059

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: FitEx
Description: FitEx is an 8 week goal-setting, behavior tracking, physical activity intervention with a low dose of social support which will be delivered virtually.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FitEx
Description: FitEx is an 8 week goal-setting, behavior tracking, physical activity intervention with a low dose of social support which will be delivered virtually.
Study: NCT05623865

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Wrist, finger, elbow range of motion and stretching exercises will be taught to the patients and given as home exercises.~In addition, patients will be given a leaflet containing illustrated and explanatory exercise visuals.
Study: NCT06437704

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain training game Lumosity
Description: . Group A, the experimental group will be trained using five selected games i.e. Speed Match, Memory Matrix, Tidal treasure, Ebb and Flow and Lost in Migration from Lumosity for a period of 30 sessions , 30 min/ day over the span of 6 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Simulation game simcity buildit
Description: Group B, the active control will be trained for the same number of sessions using a simulation game, SimCity Build it, for a period of 30 sessions , 30 min/ day over the span of 6 weeks.
Study: NCT04739176

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One-on-one rehabilitation program including computerized mirror therapy in addition to standard rehabilitation.
Description: atients will be admitted to the day hospital 2 days a week for 9 weeks. They will participate in a one-on-one rehabilitation program conducted by a multidisciplinary team including a physiotherapist, psychomotor therapist, occupational therapist and a physical activity monitor. Patients will also participate in 12 computerized mirror therapy sessions (twice a day, 2 days a week, from week 4 to 6 of the program).
Study: NCT05233059

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weekly Yoga Sessions
Description: 30 minutes of optional guided yoga online led by a 500 hour yoga teacher once a week for participants in the walking plus yoga arm. Also accompanied by a yoga based newsletter.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Movement Sessions
Description: 30 minutes of optional guided movement online led by a 500 hour yoga teacher once a week for participants in the walking arm. Also accompanied by a movement based newsletter.
Study: NCT05599711

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transitioning Together (TT) / Juntos en la Transicion (JET)
Description: 1. One individual family joining session when each family dyad meets with group therapists to establish rapport and share their own unique family's background, goals, and supports.~2. A series of four 2.5-hour multi-family group psychoeducation intervention sessions focused on problem-solving education and psychoeducational autism transition-to-adulthood content which can include independence in adulthood, community involvement, guardianship and legal issues, employment and education, health and well-being.
Study: NCT06194994

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Management Training
Description: Behavioral parent training program aimed at increasing compliance and positive behaviours while decreasing disruptive behaviours

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tuning Your Temper
Description: Cognitive behavioural treatment for children focusing on arousal reduction, problem solving and cognitive restructuring.
Study: NCT05388175

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rigid catheter
Description: Participants will be invited to positioning a rigid catheter in the manikin's trachea for surfactant aministration

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Soft catheter
Description: Participants will be invited to positioning a rigid catheter in the manikin's trachea for surfactant aministration
Study: NCT06193967

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Caregiver Praise
Description: Caregivers will provide praise for child's engagement in dietary self-monitoring behaviors as a form of positive reinforcement

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Caregiver Praise
Description: Caregivers will provide praise for child's engagement in dietary self-monitoring behaviors as a form of positive reinforcement

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gamification
Description: DSM logs will include gamification (points, levels, virtual pets) as positive reinforcement for child's engagement in dietary self-monitoring behaviors

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gamification
Description: DSM logs will include gamification (points, levels, virtual pets) as positive reinforcement for child's engagement in dietary self-monitoring behaviors
Study: NCT05599711

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual autism transition care
Description: An expedited referral will be made for participants to establish care with a BMC Autism Program Transition/Resource Specialist. Data will be abstracted from the electronic medical record on how many visits each family completes with a BMC Autism Program Transition/Resource Specialist or other BMC Developmental and Behavioral Pediatrics provider throughout the study period.
Study: NCT05213286

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Application of ZAQ and RAADS-R-DK
Description: Test of the questionnaires in each of the three groups.
Study: NCT06561074

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Given by vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase pegol-mknl
Description: Given by vein
Study: NCT05628272

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of cord blood mononuclear cells
Description: On the basis of the application of granulocyte stimulating factor, the research group was given intravenous infusion of umbilical cord blood mononuclear cells, each infusion ≥1×10\^8, once a week

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: application of granulocyte stimulating factor
Description: application of granulocyte stimulating factor

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: application of granulocyte stimulating factor
Description: application of granulocyte stimulating factor
Study: NCT03738748

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound- guided Percutaneous Neuromulation
Description: The experimental group will be treated with percutaneous neuromodulation using a needle with Physio Invasive® device, in its modality of percutaneous electrostimulation for 15 minutes, and guided by ultrasound equipment in the multifidus muscles of L-3, once a week for 4 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TENS Therapy
Description: The control group will apply a transcutaneous treatment with surface electrodes with TENS current at 170 Hz for 15 minutes in the L-3 region, once a week for 4 weeks.
Study: NCT04947787

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity referral scheme (PARS)
Description: Participants of the intervention group will receive brief physician advice and be referred to an exercise professional (e.g., physiotherapist, sports therapist) for a more intensive counseling intervention. The counseling intervention consists of an initial assessment, individual physical activity counseling (360'), a final assessment after 12 weeks, and a follow-up assessment after 24 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity advice (PAA)
Description: Participants of the control group will only receive brief physician advice regarding the promotion of physical activity and as an information sheet with tips on how to adopt a more physically active lifestyle.
Study: NCT05637125

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise for upper limb
Description: aerobic exercise for upper limb in the form of arm ergometer 3 session/week for 12 weeks. Patient started with warming up for 5 minutes in form of stretching. Patients used arm ergometer without resistance for upper limb aerobic exercise for 20 minutes and instructed to take rest if they feel tired or fatigue. The intensity was according to rate of perceive exertion, after 20 minutes, patients were asked to cool down for 5 minutes in the form of stretching at the end of an exercise session.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise for lower limb
Description: received aerobic exercise for lower limb in the form of cycling 3session/week for 12 weeks. Patient started with warming up for 5 minutes. Patients used bicycle for lower limb aerobic exercise for 20 minutes and instructed to take rest if they feel tired or fatigue. The intensity was according to rate of perceive exertion. After 20 minutes, patients were asked to cool down for 5 minutes in the form of stretching at the end of an exercise session.
Study: NCT05460676

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Description: tDCS is noninvasive brain stimulation device that modulates brain activity by delivering a low-intensity electrical current (2.0 mA) through sponge electrodes placed on the scalp.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: Participants will follow an audio track for guided mindfulness during the stimulation.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Mindfulness
Description: Participants will follow an audio track for guided mindfulness during the stimulation.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham - Transcranial Direct Current Stimulation (tDCS)
Description: The tDCS device is programmed to mimic active tDCS.
Study: NCT05349266

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ThisCART19A
Description: each patient will receive a dose level per body weight(kg) for only once.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ThisCART19A
Description: each patient will receive a dose level per body weight(kg) for only once.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ThisCART19A
Description: each patient will receive a dose level per body weight(kg) for only once.
Study: NCT06195215

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer Counselling
Description: 7 weeks peer counselling process will be carried out.
Study: NCT05354674

Intervention type: DRUG
Intervention: Bevacizumab
Description: AEM A：The specialist's decision to add bevacizumab to chemotherapy will be based on their own judgment~ARM B：The patient's PET/CT imaging, pathology, and clinical information were input into the signature, and the FOLFOX+Bevacizumab regimen was selected when the output label was 1. FOLFOXIRI chemotherapy regimen was selected when the output label was 0

Intervention type: DRUG
Intervention: Bevacizumab
Description: AEM A：The specialist's decision to add bevacizumab to chemotherapy will be based on their own judgment~ARM B：The patient's PET/CT imaging, pathology, and clinical information were input into the signature, and the FOLFOX+Bevacizumab regimen was selected when the output label was 1. FOLFOXIRI chemotherapy regimen was selected when the output label was 0
Study: NCT06332469

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet based education and support program for patients awaiting kidney transplantation
Description: A guided internet based support an education program consisting of 9 modules running over 9 weeks. First, an introductory module is given that involves goal setting, followed by two educational modules with information regarding kidney disease, treatment and self-care in severe renal failure and while waiting for kidney transplantation, and kidney transplant-specific areas. Supportive content consist of three behavioral components spread over five modules/weeks and are based on cognitive behavioural therapy principles. The last module is a summation focusing on consolidating the knowledge learned during the program.~Each module consists of texts, illustrations, short films, reminders to practice physical activity and weekly homework for which the participants receive feedback from a contact person.
Study: NCT06641765

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continous Glucose Monitoring
Description: 10 days of real time open access to Continous Glucose Monitoring - either at defined time intervals (Group 2) or continuously for 9 months (Group 3).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continous Glucose Monitoring
Description: 10 days of real time open access to Continous Glucose Monitoring - either at defined time intervals (Group 2) or continuously for 9 months (Group 3).
Study: NCT05146622

Intervention type: BEHAVIORAL
Intervention: Workplaces in the World
Description: Formative research activities to better understand attitudes and behaviors of outdoor workers with respect to UV safety.
Study: NCT06378710

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Optimized PEEP
Description: Optimized PEEP
Study: NCT06187415

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile app to reduce harm of chemsex
Description: Access to the mobile app which includes PrEP diary, demistification of chemsex urban legends, information on the location of needle and syringe services program, and alert sending to emergency contact.
Study: NCT04930250

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage powder with 12% oat bran processed with method A
Description: 50g of beverage powder to be reconstituted with 330ml of water. Subjects will orally consume one of the five test products in a random order over the five test visits.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage powder with 12% oat bran processed with method B
Description: 50g of beverage powder to be reconstituted with 330ml of water. Subjects will orally consume one of the five test products in a random order over the five test visits.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage powder with 12% oat bran processed with method C
Description: 50g of beverage powder to be reconstituted with 330ml of water. Subjects will orally consume one of the five test products in a random order over the five test visits.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Comparator: Minimally-processed oat bran (Positive Control)
Description: 50g of beverage powder to be reconstituted with 330ml of water. Subjects will orally consume one of the five test products in a random order over the five test visits.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator: Readily-digestible carbohydrate (negative control)
Description: 50g of beverage powder to be reconstituted with 330ml of water. Subjects will orally consume one of the five test products in a random order over the five test visits.
Study: NCT05578521

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cerebralcare pills
Description: a dose of 2 packages, twice a day of Cerebralcare pills

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cerebralcare pills placebo
Description: Cerebralcare pills placebo will be administrated at the same rate with experimental group
Study: NCT05349461

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Complete patellofemoral articular contact
Description: The patellofemoral condition is in constant contact with the femoral trochlea when the knee is bent from 30 to 90 degrees during the No thumb test.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Incomplete patellofemoral articular contact
Description: The patellofemoral condition is in no constant contact with the femoral trochlea when the knee is bent from 30 to 90 degrees during the No thumb test.
Study: NCT05134974

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phentolamine Ophthalmic Solution 0.75%
Description: 0.75% phentolamine ophthalmic solution (Nyxol), a non-selective alpha-1 and alpha-2 adrenergic antagonist

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Phentolamine Ophthalmic Solution Vehicle
Description: Phentolamine Ophthalmic Solution Vehicle
Study: NCT05164523

Intervention type: DIAGNOSTIC_TEST
Intervention: 24-hour rhythm Holter
Description: Before starting their newly prescribed medication, the investigators will apply 24-hour rhythm Holter and repeat it at the end of the trial.

Intervention type: DIAGNOSTIC_TEST
Intervention: 24-hour rhythm Holter
Description: Before starting their newly prescribed medication, the investigators will apply 24-hour rhythm Holter and repeat it at the end of the trial.

Intervention type: DIAGNOSTIC_TEST
Intervention: 36 item Short Form Survey (SF-36)
Description: Before starting their newly prescribed medication, the investigators will apply SF-36 survey and repeat it at the end of the trial.

Intervention type: DIAGNOSTIC_TEST
Intervention: 36 item Short Form Survey (SF-36)
Description: Before starting their newly prescribed medication, the investigators will apply SF-36 survey and repeat it at the end of the trial.
Study: NCT04248010

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: neuroConn DC-Stimulator MR
Description: standard tDCS, active \& sham

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: neuroConn DC-Stimulator MR
Description: standard tDCS, active \& sham

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Soterix MxN HD-tES
Description: HD-tDCS, active \& sham

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Soterix MxN HD-tES
Description: HD-tDCS, active \& sham

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Soterix MxN HD-tES
Description: HD-tDCS, active \& sham
Study: NCT04931342

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipatasertib
Description: Ipatasertib will be administered by mouth once a day on Days 1-21 of each cycle. (Cycle length = 28 days)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cobimetinib
Description: Cobimetinib will be administered by mouth once a day on Days 1-21 of each cycle. (Cycle length=28 days)
Study: NCT06740630

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV 20
Description: The 20-valent pneumococcal conjugate vaccine co-administered intramuscularly. In some countries PCV will only be administered depending on the availability, country's registration status and national recommendations for pneumococcal vaccination at the time of study conduct.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PCV 20
Description: The 20-valent pneumococcal conjugate vaccine co-administered intramuscularly. In some countries PCV will only be administered depending on the availability, country's registration status and national recommendations for pneumococcal vaccination at the time of study conduct.